These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1890610)

  • 1. Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen.
    Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1033-7. PubMed ID: 1890610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats.
    Ichikawa N; Naora K; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Nov; 44(11):915-20. PubMed ID: 1361537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats.
    Naora K; Katagiri Y; Iwamoto K; Tanaka K; Yamaguchi T; Sekine Y
    J Antimicrob Chemother; 1992 Nov; 30(5):673-83. PubMed ID: 1337351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible reduction in the renal clearance of ciprofloxacin by fenbufen in rats.
    Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
    J Pharm Pharmacol; 1990 Oct; 42(10):704-7. PubMed ID: 1982142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitated transport of cefodizime into the rat central nervous system.
    Matsushita H; Suzuki H; Sugiyama Y; Sawada Y; Iga T; Kawaguchi Y; Hanano M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):620-5. PubMed ID: 1941610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animals.
    Taga F; Kobayashi F; Saito S; Ooie T; Kawahara F; Uchida H; Shimada J; Hori S; Sakai O
    Arzneimittelforschung; 1990 Aug; 40(8):900-4. PubMed ID: 2173611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
    Ichikawa N; Naora K; Iwamoto K
    Biol Pharm Bull; 1994 Jan; 17(1):152-5. PubMed ID: 8148807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
    Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M; Spector R
    J Pharmacol Exp Ther; 1989 Sep; 250(3):979-84. PubMed ID: 2506338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats.
    Jaehde U; Langemeijer MW; de Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1140-6. PubMed ID: 1469626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.
    Kamali F; Ashton CH; Marsh VR; Cox J
    Antimicrob Agents Chemother; 1998 May; 42(5):1256-8. PubMed ID: 9593161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a pharmacokinetic interaction between ciprofloxacin and fenbufen.
    Kamali F
    J Clin Pharm Ther; 1994 Aug; 19(4):257-9. PubMed ID: 7989405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
    Guiol C; Ledoussal C; Surgé JM
    Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats.
    Katagiri Y; Naora K; Ichikawa N; Hayashibara M; Iwamoto K
    J Pharm Pharmacol; 1989 Oct; 41(10):717-9. PubMed ID: 2575153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A minor possibility of pharmacokinetic interaction between enoxacin and fenbufen in rats.
    Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
    J Pharmacobiodyn; 1990 Feb; 13(2):90-6. PubMed ID: 2384853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and pharmacokinetic studies with fenbufen in man.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):728-35. PubMed ID: 7192124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.
    Broadwell RD; Sofroniew MV
    Exp Neurol; 1993 Apr; 120(2):245-63. PubMed ID: 8491281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous high-performance liquid chromatographic determination of ciprofloxacin, fenbufen and felbinac in rat plasma.
    Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
    J Chromatogr; 1990 Aug; 530(1):186-91. PubMed ID: 2277110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.